3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Recurrence
1
Neoplasms
1
Lymphoma, Follicular
1
Depressive Disorder, Major
1
Brain Neoplasms
1
Interventions
Surveys and Questionnaires
15
Radiosurgery
14
Magnetic Resonance Imaging
11
Magnetic Resonance Spectroscopy
10
Neuropsychological Tests
8
Radiotherapy
7
Radiation
4
Blood Specimen Collection
4
Patient Reported Outcome Measures
3
sacituzumab govitecan
2
Trastuzumab
2
Surgical Procedures, Operative
2
Quality of Life
2
Physical Examination
2
Phlebotomy
2
Perfusion Magnetic Resonance Imaging
2
Lead
2
Lapatinib
2
Interviews as Topic
2
Immunotherapy
2
Drug Therapy
2
Data Collection
2
Brain Mapping
2
Bevacizumab
2
Amplified Fragment Length Polymorphism Analysis
2
Aminolevulinic Acid
2
trastuzumab deruxtecan
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Brain Neoplasms
×
Transcranial Magnetic Stimulation
×
Clear all
NCT04501731
2022-05-25
5C-pilot
University of Nottingham
Unknown
10 enrolled